Axol Bioscience introduces CiPA-validated human stem cell-derived ventricular cardiomyocytes to help improve drug discovery 8 Jun Written By Alexandra Collingbourne Alexandra Collingbourne
Axol Bioscience introduces CiPA-validated human stem cell-derived ventricular cardiomyocytes to help improve drug discovery 8 Jun Written By Alexandra Collingbourne Alexandra Collingbourne
